This website uses cookies to enhance the user experience.
21st logo
||
L

LAB PHARMA AS997 105 028

Limited company
c/o Ter Rek AS Olav Selvaags plass 4 0252 OSLO, Norge

LAB PHARMA AS

Operating
Lab Pharma AS er en stor aktør innen helsekost
Utvikling og salg av helsekostprodukter og naturlegemidler, samt alt som hører naturlig til dette, herunder å delta i andre selskaper.
Postordrehandel/netthandel med helsekostprodukter og naturlegemidler.

Links

Organization

Chairman of the board
Years since formation
15 years
since Jul 4, 2011
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
500
1 share class
Total number of shareholders
1
company
Belongs to group of

Financials

Total operating income 2025
50,674,735
NOK
Annual total result 2025
11,644,571
NOK
Total equity 2025
5,433,832
NOK
Last update: Aug 24, 2026

Management

Management / administration

NameRoleShares
Managing Director/CEO
100 %
indirectly

Board

NameRoleShares
Chairman
100 %
indirectly
Board Member-

Others

NameRoleShares
N
NARVESEN REVISJON AS
Auditor-
T
TANDEM AS
Accountant-
D
DIALOG REGNSKAP AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Managing Director/CEO, Chairman
100 %
indirectly
Last update: Nov 18, 2025

Ownership

Company shareholders

NameShare classTotal number of sharesShare
T
TER REK AS
Ordinary shares
500
100 %
Last update: Jun 2, 2025

Group structure

  • Total operating income 2025: NOK 546,750
    Operating profit 2025: NOK 146,991
    Employees: 0

Financials

in NOK

Summary

Year20252024202320222021
Total operating income
50,674,735
26,222,450
30,156,578
22,364,667
22,599,523
Annual Total Result
11,644,571
-3,881,095
1,652,322
-660,940
-893,932
Total assets
14,527,938
5,604,759
8,971,116
4,765,216
4,713,360
Total liabilities
9,094,107
7,815,499
7,300,761
4,747,182
4,034,386
Total equity
5,433,832
-2,210,740
1,670,356
18,034
678,974

P&L

Year20252024202320222021
Total operating income
50,674,735
26,222,450
30,156,578
22,364,667
22,599,523
Total operating costs
38,884,501
29,158,835
29,381,281
24,221,998
23,948,508
Operating result
11,790,234
-2,936,385
775,297
-1,857,331
-1,348,985
Financial income/costs
798,373
302,080
1,343,063
1,009,972
202,917
Profit before tax
12,588,607
-2,634,304
2,118,361
-847,359
-1,146,067
Total tax & extraordinary income/cost
944,036
1,246,791
466,039
-186,419
-252,135
Annual Total Result
11,644,571
-3,881,095
1,652,322
-660,940
-893,932

Balance overview

Year20252024202320222021
Total fixed assets
1,056,798
525,729
2,062,384
2,498,388
2,326,655
Total current assets
13,471,140
5,079,030
6,908,732
2,266,828
2,386,705
Total assets
14,527,938
5,604,759
8,971,116
4,765,216
4,713,360
Short term debt
9,094,107
7,815,499
7,300,761
4,747,182
4,034,386
Long term debt
0
0
0
0
0
Total liabilities
9,094,107
7,815,499
7,300,761
4,747,182
4,034,386
Contributed capital
500,000
500,000
500,000
500,000
500,000
Retained earnings
4,933,832
-2,710,740
1,170,356
-481,966
178,974
Total equity
5,433,832
-2,210,740
1,670,356
18,034
678,974
Total equity and liabilities
14,527,938
5,604,759
8,971,116
4,765,216
4,713,360

Classification

21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises